These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 27518458

  • 1. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F, Ashofteh M, Homayouni A, Abbaspour M, Nokhodchi A, Garekani HA.
    Colloids Surf B Biointerfaces; 2016 Nov 01; 147():258-264. PubMed ID: 27518458
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A.
    Eur J Pharm Biopharm; 2014 Sep 01; 88(1):261-74. PubMed ID: 24952357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A, Sadeghi F, Varshosaz J, Afrasiabi Garekani H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2014 Oct 01; 122():591-600. PubMed ID: 25124835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q, Qiu Z, Huang D, Lu T, Zhang ZJ, Luo D, Pan P, Zhang L, Liu Y, Guan S, Li Q.
    Eur J Pharm Sci; 2019 Feb 01; 128():222-231. PubMed ID: 30553058
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
    Fael H, Ràfols C, Demirel AL.
    J Pharm Sci; 2018 Sep 01; 107(9):2428-2438. PubMed ID: 29859957
    [Abstract] [Full Text] [Related]

  • 15. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 04; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S.
    J Pharm Pharm Sci; 2010 Sep 04; 13(4):589-606. PubMed ID: 21486533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.
    Martínez-Ohárriz MC, Rodríguez-Espinosa C, Martín C, Goñi MM, Tros-Ilarduya MC, Sánchez M.
    Drug Dev Ind Pharm; 2002 Jul 04; 28(6):717-25. PubMed ID: 12149965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.